Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1998 Sep;51(9):676–678. doi: 10.1136/jcp.51.9.676

Hepatitis G virus infection in lymphoma and in blood donors.

J Minton 1, A Iqbal 1, A Eskiturk 1, W Irving 1, J Davies 1
PMCID: PMC500905  PMID: 9930072

Abstract

AIMS: To determine whether the recently described flavivirus, hepatitis G virus (HGV), might contribute to the pathogenesis of lymphoma by testing for the presence of HGV RNA in sera from patients attending lymphoma clinics; to compare the incidence of HGV RNA in lymphoma patients with that in normal blood donors; and to look for potential risk factors for HGV infection and for evidence of hepatic disease in the HGV positive patients. METHODS: Sera were examined from 76 patients with lymphoma and 100 blood donors for the presence of HGV RNA using reverse transcriptase polymerase chain reaction (RT-PCR). RESULTS: HGV RNA was detected in 10% of patients' sera, but only in 1% of blood donor samples. HGV infection was found in patients with various different types of lymphoma, including Hodgkin's disease and non-Hodgkin's lymphoma. The majority (75%) of patients who were HGV PCR positive had undergone transfusion, but only 30% of those who were HGV PCR negative had received blood products. In addition, the number of donor exposures per HGV positive patient was approximately twice that of the HGV negative group. CONCLUSIONS: The data suggest (1) that HGV is present in the normal blood donor population; (2) that patients with lymphoma are at risk of acquiring HGV because of their exposure to blood products; and (3) that persistent HGV infection does not appear to cause serious liver disease in these patients.

Full text

PDF
676

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aikawa T., Sugai Y., Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med. 1996 Jan 18;334(3):195–196. doi: 10.1056/NEJM199601183340316. [DOI] [PubMed] [Google Scholar]
  2. Alter H. J., Nakatsuji Y., Melpolder J., Wages J., Wesley R., Shih J. W., Kim J. P. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med. 1997 Mar 13;336(11):747–754. doi: 10.1056/NEJM199703133361102. [DOI] [PubMed] [Google Scholar]
  3. Alter M. J., Gallagher M., Morris T. T., Moyer L. A., Meeks E. L., Krawczynski K., Kim J. P., Margolis H. S. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med. 1997 Mar 13;336(11):741–746. doi: 10.1056/NEJM199703133361101. [DOI] [PubMed] [Google Scholar]
  4. Bralet M. P., Roudot-Thoraval F., Pawlotsky J. M., Bastie A., Tran Van Nhieu J., Duval J., Dhumeaux D., Zafrani E. S. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology. 1997 Jan;112(1):188–192. doi: 10.1016/s0016-5085(97)70234-8. [DOI] [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. De Vita S., Sansonno D., Dolcetti R., Ferraccioli G., Carbone A., Cornacchiulo V., Santini G., Crovatto M., Gloghini A., Dammacco F. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood. 1995 Sep 1;86(5):1887–1892. [PubMed] [Google Scholar]
  7. Fiordalisi G., Zanella I., Mantero G., Bettinardi A., Stellini R., Paraninfo G., Cadeo G., Primi D. High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis. 1996 Jul;174(1):181–183. doi: 10.1093/infdis/174.1.181. [DOI] [PubMed] [Google Scholar]
  8. Heringlake S., Osterkamp S., Trautwein C., Tillmann H. L., Böker K., Muerhoff S., Mushahwar I. K., Hunsmann G., Manns M. P. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet. 1996 Dec 14;348(9042):1626–1629. doi: 10.1016/S0140-6736(96)04413-3. [DOI] [PubMed] [Google Scholar]
  9. Hwang S. J., Lu R. H., Chan C. Y., Wang Y. J., Wu J. C., Lee S. D. The role of hepatitis G virus infection in patients with acute posttransfusion hepatitis in Taiwan. Gastroenterology. 1997 Apr;112(4):1260–1264. doi: 10.1016/s0016-5085(97)70138-0. [DOI] [PubMed] [Google Scholar]
  10. Jarvis L. M., Davidson F., Hanley J. P., Yap P. L., Ludlam C. A., Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet. 1996 Nov 16;348(9038):1352–1355. doi: 10.1016/s0140-6736(96)04041-x. [DOI] [PubMed] [Google Scholar]
  11. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 1989 May 18;339(6221):237–238. doi: 10.1038/339237a0. [DOI] [PubMed] [Google Scholar]
  12. Linnen J., Wages J., Jr, Zhang-Keck Z. Y., Fry K. E., Krawczynski K. Z., Alter H., Koonin E., Gallagher M., Alter M., Hadziyannis S. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996 Jan 26;271(5248):505–508. doi: 10.1126/science.271.5248.505. [DOI] [PubMed] [Google Scholar]
  13. Madejón A., Fogeda M., Bartolomé J., Pardo M., González C., Cotonat T., Carreńo V. GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D. Gastroenterology. 1997 Aug;113(2):573–578. doi: 10.1053/gast.1997.v113.pm9247478. [DOI] [PubMed] [Google Scholar]
  14. Miyakawa Y., Mayumi M. Hepatitis G virus--a true hepatitis virus or an accidental tourist? N Engl J Med. 1997 Mar 13;336(11):795–796. doi: 10.1056/NEJM199703133361109. [DOI] [PubMed] [Google Scholar]
  15. Moldvay J., Deny P., Pol S., Brechot C., Lamas E. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization. Blood. 1994 Jan 1;83(1):269–273. [PubMed] [Google Scholar]
  16. Nakatsuji Y., Shih J. W., Tanaka E., Kiyosawa K., Wages J., Jr, Kim J. P., Alter H. J. Prevalence and disease association of hepatitis G virus infection in Japan. J Viral Hepat. 1996 Nov;3(6):307–316. doi: 10.1111/j.1365-2893.1996.tb00103.x. [DOI] [PubMed] [Google Scholar]
  17. Neilson J., Harrison P., Milligan D. W., Skidmore S. J., Collingham K. E. Hepatitis G virus in long-term survivors of haematological malignancy. Lancet. 1996 Jun 8;347(9015):1632–1633. doi: 10.1016/s0140-6736(96)91122-8. [DOI] [PubMed] [Google Scholar]
  18. Pozzato G., Mazzaro C., Crovatto M., Modolo M. L., Ceselli S., Mazzi G., Sulfaro S., Franzin F., Tulissi P., Moretti M. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood. 1994 Nov 1;84(9):3047–3053. [PubMed] [Google Scholar]
  19. Silvestri F., Baccarani M. Hepatitis C virus-related lymphomas. Br J Haematol. 1997 Dec;99(3):475–480. doi: 10.1046/j.1365-2141.1997.4023216.x. [DOI] [PubMed] [Google Scholar]
  20. Simons J. N., Leary T. P., Dawson G. J., Pilot-Matias T. J., Muerhoff A. S., Schlauder G. G., Desai S. M., Mushahwar I. K. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1995 Jun;1(6):564–569. doi: 10.1038/nm0695-564. [DOI] [PubMed] [Google Scholar]
  21. Weiss L. M., Movahed L. A., Warnke R. A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med. 1989 Feb 23;320(8):502–506. doi: 10.1056/NEJM198902233200806. [DOI] [PubMed] [Google Scholar]
  22. Wong-Staal F., Gallo R. C. Human T-lymphotropic retroviruses. Nature. 1985 Oct 3;317(6036):395–403. doi: 10.1038/317395a0. [DOI] [PubMed] [Google Scholar]
  23. Yoshiba M., Okamoto H., Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 1995 Oct 28;346(8983):1131–1132. doi: 10.1016/s0140-6736(95)91802-7. [DOI] [PubMed] [Google Scholar]
  24. Zignego A. L., Macchia D., Monti M., Thiers V., Mazzetti M., Foschi M., Maggi E., Romagnani S., Gentilini P., Bréchot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol. 1992 Jul;15(3):382–386. doi: 10.1016/0168-8278(92)90073-x. [DOI] [PubMed] [Google Scholar]
  25. zur Hausen H., Schulte-Holthausen H., Klein G., Henle W., Henle G., Clifford P., Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970 Dec 12;228(5276):1056–1058. doi: 10.1038/2281056a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES